Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in Japan-Reference-Cited by-同舟云学术

Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in Japan

Published:2017-05-30 Issue:1 Volume:53 Page:119-128
ISSN:0944-1174
Container-title:Journal of Gastroenterology
language:en
Short-container-title:J Gastroenterol

Author:

Suda Goki,Furusyo Norihiro,Toyoda Hidenori,Kawakami Yoshiiku,Ikeda Hiroki,Suzuki Michihiro,Arataki Keiko,Mori Nami,Tsuji Keiji,Katamura Yoshio,Takaguchi Koichi,Ishikawa Toru,Tsuji Kunihiko,Shimada Noritomo,Hiraoka Atsushi,Yamsaki Sho,Nakai Masato,Sho Takuya,Morikawa Kenichi,Ogawa Koji,Kudo Mineo,Nagasaka Atsushi,Furuya Ken,Yamamoto Yoshiya,Kato Kanji,Ueno Yoshiyuki,Iio Etsuko,Tanaka Yasuhito,Kurosaki Masayuki,Kumada Takashi,Chayama Kazuaki,Sakamoto Naoya

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

https://link.springer.com/article/10.1007/s00535-017-1353-y/fulltext.html

Reference42 articles.

1. Mohd Hanafiah K, Groeger J, Flaxman AD, et al. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013;57(4):1333–42.

2. Seeff LB. Natural history of chronic hepatitis C. Hepatology. 2002;36(5 Suppl 1):S35–46.

3. Gower E, Estes C, Blach S, et al. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014;61(1 Suppl):S45–57.

4. Mizokami M, Yokosuka O, Takehara T, et al. Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial. Lancet Infect Dis. 2015;15(6):645–53.

5. Omata M, Nishiguchi S, Ueno Y, et al. Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open-label, phase 3 trial. J Viral Hepat. 2014;21(11):762–8.

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of direct-acting antiviral regimens for end-stage renal disease patients with HCV infection: a systematic review and network meta-analysis;Frontiers in Public Health;2023-09-29

2. Direct‑acting antiviral treatment is safe and effective for chronic HCV patients with psychiatric disorders;Experimental and Therapeutic Medicine;2023-07-07

3. Management of dialysis patients with hepatitis C virus in the era of direct‐acting antiviral therapy;Therapeutic Apheresis and Dialysis;2023-05-22

4. A Systematic Review of Direct-Acting Antivirals for Hepatitis C in Advanced CKD;Kidney International Reports;2023-02

5. Prophylactic tenofovir alafenamide for hepatitis B virus reactivation and reactivation‐related hepatitis;Journal of Medical Virology;2023-01-10